|
1
|
Cicchillitti L, Della Corte A, Di Michele
M, Donati MB, Rotilio D and Scambia G: Characterisation of a
multimeric protein complex associated with ERp57 within the nucleus
in paclitaxel-sensitive and -resistant epithelial ovarian cancer
cells: The involvement of specific conformational states of
β-actin. Int J Oncol. 37:445–454. 2010.PubMed/NCBI
|
|
2
|
Bovicelli A, D’Andrilli G and Giordano A:
New players in ovarian cancer. J Cell Physiol. 226:2500–2504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurman RJ and Shih IeM: The origin and
pathogenesis of epithelial ovarian cancer: a proposed unifying
theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim A, Ueda Y, Naka T and Enomoto T:
Therapeutic strategies in epithelial ovarian cancer. J Exp Clin
Cancer Res. 31:142012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rein DT, Volkmer A, Bauerschmitz G, et al:
Combination of a MDR1-targeted replicative adenovirus and
chemotherapy for the therapy of pretreated ovarian cancer. J Cancer
Res Clin Oncol. 138:603–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kavallaris M: Microtubules and resistance
to tubulin-binding agents. Nat Rev Cancer. 10:194–204. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Umezu T, Shibata K, Kajiyama H, et al:
Taxol resistance among the different histological subtypes of
ovarian cancer may be associated with the expression of class III
beta-tubulin. Int J Gynecol Pathol. 27:207–212. 2008.PubMed/NCBI
|
|
8
|
Wang Y, Chen Q, Jin S, et al:
Up-regulation of P-glycoprotein is involved in the increased
paclitaxel resistance in human esophageal cancer radioresistant
cells. Scand J Gastroenterol. 47:802–808. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan XD, Li M, Yuan Y, Mao N and Pan LY:
Biological comparison of ovarian cancer resistant cell lines to
cisplatin and Taxol by two different administrations. Oncol Rep.
17:1163–1169. 2007.PubMed/NCBI
|
|
10
|
Carmichael J, DeGraff WG, Gazdar AF, Minna
JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated
colorimetric assay: assessment of chemosensitivity testing. Cancer
Res. 47:936–942. 1987.PubMed/NCBI
|
|
11
|
Preusser M, Spiegl-Kreinecker S, Lötsch D,
et al: Trabectedin has promising antineoplastic activity in
high-grade meningioma. Cancer. March 5–2012.(Epub ahead of print).
View Article : Google Scholar
|
|
12
|
Gorg A, Obermaier C, Boguth G, et al: The
current state of two-dimensional electrophoresis with immobilized
pH gradients. Electrophoresis. 21:1037–1053. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan XD, Pan LY, Yuan Y, Lang JH and Mao N:
Identification of platinum-resistance associated proteins through
proteomic analysis of human ovarian cancer cells and their
platinum-resistant sublines. J Proteome Res. 6:772–780. 2007.
View Article : Google Scholar
|
|
14
|
Joubert-Caron R, Le Caer JP, Montandon F,
et al: Protein analysis by mass spectrometry and sequence database
searching: a proteomic approach to identify human lymphoblastoid
cell line proteins. Electrophoresis. 21:2566–2575. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Swenerton K, Muss H and Robinson E:
Salvage Chemotherapy for Refractory Disease. Ovarian Cancer
Controversies on Management. Gershenson DM and McGuire WP:
Churchill Livingstone; New York: pp. 169–194. 1998
|
|
16
|
Hsu SM, Raine L and Fanger H: Use of
avidin-biotin-peroxidase complex (ABC) in immunoperoxidase
techniques: a comparison between ABC and unlabeled antibody (PAP)
procedures. J Histochem Cytochem. 29:577–580. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beamer LC, Grant ML, Espenschied CR, et
al: Reflex immunohistochemistry and microsatellite instability
testing of colorectal tumors for Lynch syndrome among US cancer
programs and follow-up of abnormal results. J Clin Oncol.
30:1058–1063. 2012. View Article : Google Scholar
|
|
18
|
Tanaka Y, Fujiwara K, Tanaka H, Maehata K
and Kohno I: Paclitaxel inhibits expression of heat shock protein
27 in ovarian and uterine cancer cells. Int J Gynecol Cancer.
14:616–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alli E, Yang JM, Ford JM and Hait WN:
Reversal of stathmin-mediated resistance to paclitaxel and
vinblastine in human breast carcinoma cells. Mol Pharmacol.
71:1233–1240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song TF, Zhang ZF, Liu L, Yang T, Jiang J
and Li P: Small interfering RNA-mediated silencing of heat shock
protein 27 (HSP27) Increases chemosensitivity to paclitaxel by
increasing production of reactive oxygen species in human ovarian
cancer cells (HO8910). J Int Med Res. 37:1375–1388. 2009.
View Article : Google Scholar
|
|
21
|
Balasubramani M, Nakao C, Uechi GT, et al:
Characterization and detection of cellular and proteomic
alterations in stable stathmin-overexpressing, taxol-resistant
BT549 breast cancer cells using offgel IEF/PAGE difference gel
electrophoresis. Mutat Res. 722:154–164. 2011. View Article : Google Scholar
|
|
22
|
Estornes Y, Gay F, Gevrey JC, et al:
Differential involvement of destrin and cofilin-1 in the control of
invasive properties of Isreco1 human colon cancer cells. Int J
Cancer. 121:2162–2171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castro MA, Dal-Pizzol F, Zdanov S, et al:
CFL1 expression levels as a prognostic and drug resistance marker
in nonsmall cell lung cancer. Cancer. 116:3645–3655. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muller CB, de Barros RL, Castro MA, et al:
Validation of cofilin-1 as a biomarker in non-small cell lung
cancer: application of quantitative method in a retrospective
cohort. J Cancer Res Clin Oncol. 137:1309–1316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishimura S, Tsuda H, Kataoka F, et al:
Overexpression of cofilin 1 can predict progression-free survival
in patients with epithelial ovarian cancer receiving standard
therapy. Hum Pathol. 42:516–521. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vartiainen MK, Mustonen T, Mattila PK, et
al: The three mouse actin-depolymerizing factor/cofilins evolved to
fulfill cell-type-specific requirements for actin dynamics. Mol
Biol Cell. 13:183–194. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai YP, Bongalon S, Mutafova-Yambolieva VN
and Yamboliev IA: Distinct effects of contraction agonists on the
phosphorylation state of cofilin in pulmonary artery smooth muscle.
Adv Pharmacol Sci. 2008:3627412008.PubMed/NCBI
|
|
28
|
Klamt F, Zdanov S, Levine RL, et al:
Oxidant-induced apoptosis is mediated by oxidation of the
actin-regulatory protein cofilin. Nat Cell Biol. 11:1241–1246.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bernstein BW and Bamburg JR: ADF/cofilin:
a functional node in cell biology. Trends Cell Biol. 20:187–195.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Teng B, Lukasz A and Schiffer M: The
ADF/cofilin-pathway and actin dynamics in podocyte injury. Int J
Cell Biol. 2012:3205312012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruegg J, Holsboer F, Turck C and Rein T:
Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by
analysis of hormone-resistant cells. Mol Cell Biol. 24:9371–9382.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scott RW, Hooper S, Crighton D, et al: LIM
kinases are required for invasive path generation by tumor and
tumor-associated stromal cells. J Cell Biol. 191:169–185. 2010.
View Article : Google Scholar : PubMed/NCBI
|
